VPF
PFE icon

Vantage Point Financial’s Pfizer PFE Stock Holding History

Vantage Point Financial’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$515K Buy
21,406
+150
+0.7% +$3.92K 0.16% 95
2026
Q1 		$597K Buy
21,256
+514
+2% +$13.7K 0.21% 87
2025
Q4 		$516K Buy
20,742
+1,318
+7% +$33.2K 0.18% 92
2025
Q3 		$495K Buy
19,424
+293
+2% +$7.23K 0.19% 85
2025
Q2 		$464K Sell
19,131
-243
-1% -$5.67K 0.2% 82
2025
Q1 		$491K Buy
19,374
+1,081
+6% +$28.3K 0.25% 64
2024
Q4 		$485K Buy
+18,293
New +$496K 0.26% 63

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Vantage Point Financial's PFE Position: Q2 2026 in Review

Vantage Point Financial increased its Pfizer (PFE) stake by 0.71% in Q2 2026, buying an estimated $3.92K and bringing the position to 21,406 shares worth $515K. The position accounts for 0.16% of the portfolio, ranked #95.

Vantage Point Financial first reported a position in PFE in Q4 2024 and has held it in 7 quarters since. The position peaked at $597K in Q1 2026. 2,822 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Vantage Point Financial held 21,406 shares of Pfizer worth $515K as of Q2 2026.
  • Vantage Point Financial bought 150 Pfizer shares in Q2 2026, an estimated $3.92K.
  • Pfizer made up 0.16% of Vantage Point Financial's portfolio in Q2 2026, its #95 holding.
  • Vantage Point Financial first reported a position in Pfizer in Q4 2024 and has held it in 7 quarters since.
  • Vantage Point Financial's Pfizer position peaked at $597K in Q1 2026.
  • 2,822 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Vantage Point Financial's 13F filing for Q2 2026, filed 14 Aug 2026.